Sunny Pharmtech Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was TWD 428.83 million compared to TWD 359.59 million a year ago. Net loss was TWD 63.32 million compared to TWD 170.24 million a year ago.

Basic loss per share from continuing operations was TWD 0.44 compared to TWD 1.23 a year ago. Diluted loss per share from continuing operations was TWD 0.44 compared to TWD 1.23 a year ago.